Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > pSivida Limited Describes Strategy for Further Clinical Trials

February 18th, 2005

pSivida Limited Describes Strategy for Further Clinical Trials

Abstract:
Dr. Aston discusses the importance of the recently-announced successful Phase IIa clinical trials of the company's lead product, BrachySil(TM) for liver cancer, as well as the company's plans for clinical trials and commercialization of the product. In the most recent trial, it was demonstrated that BrachySil(TM) is safe and effective in tumor regression with increased efficacy.

Source:
businesswire

Bookmark:

Related News Press

Possible Futures

Space Solar Power: Key to a Livable Planet Earth June 10th, 2013

Global Nanotechnology Drug Delivery Market 2012-2016 June 10th, 2013

Nanorobot tetanus treatment animation June 9th, 2013

New horizons to drive the future of Medicine: European Technology Platform on Nanomedicine intends to lead the domain June 8th, 2013

Nanomedicine

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Announcements

Less is More: Novel Cellulose Structure Requires Fewer Enzymes to Process Biomass to Fuel June 19th, 2013

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013